Celcuity在乳腺癌领域取得胜利后,着眼于巨大的市场机遇Celcuity eyes big market opportunity after breast cancer win

动脉网
Jul 29

Armed with positive phase 3 results with lead drug gedatolisib in breast cancer, Celcuity is preparing for an FDA filing and possible launch into what could be a blockbuster market.凭借其先导药物gedatolisib在...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10